Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy

Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy

Background In patients with stage III melanoma, despite surgical resection and adjuvant systemic therapy, locoregional recurrences still occur. The randomized, phase III Trans-Tasman Radiation Oncology Group (TROG) 02.01 trial demonstrated that adjuvant radiotherapy (RT) after complete lymphadenecto...

Full description

Bibliographic Details
Main Authors: Wei Wang, Andrew Haydon, Rebecca Johnson, Elisabeth Livingstone, Zeynep Eroglu, Grant A McArthur, Douglas B Johnson, Prachi Bhave, Georgina Long, Adnan Khattak, Matteo S Carlino, Johanna Mangana, Katharina Kahler, Angela Hong, Serigne N Lo, Hui-Ling Yeoh, Alexander Maxwell Menzies, Ozgecan Dulgar, Georg C Lodde, Axel Hausschild
Format: Article
Language:English
Published: BMJ Publishing Group 2023-03-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/11/3/e006629.full

Internet

https://jitc.bmj.com/content/11/3/e006629.full

Similar Items